4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-23-042454
President and Chief Executive acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Curran Terrie President and Chief Executive | 2023-07-14 | Grant or award | +200,000 | 389,671 | D | ||
| Derivatives | |||||||
| Curran Terrie President and Chief Executive | 2023-07-14 | Returned to the company · Stock Option | −175,000 | 0 | D | ||
| Curran Terrie President and Chief Executive | 2023-07-14 | Returned to the company · Stock Option | −225,000 | 0 | D | ||
Loading xslF345X05/doc4.xml…